J. Khng

Inhibition of CD44 expression in hepatocellular carcinoma cells enhances apoptosis, chemosensitivity, and reduces tumorigenesis and invasion

Viraj J. Jasinghe, C. Chen, Jianbiao Zhou, 2008, Cancer Chemotherapy and Pharmacology.

Genome-wide mapping of Myc binding and gene regulation in serum-stimulated fibroblasts

A. Trumpp, W. Sung, Chia-Lin Wei, 2011, Oncogene.

In vivo activity of ABT-869, a multi-target kinase inhibitor, against acute myeloid leukemia with wild-type FLT3 receptor.

Hanry Yu, Chonglei Bi, K. Glaser, 2008, Leukemia research.

ABT-869, a multi-targeted tyrosine kinase inhibitor, in combination with rapamycin is effective for subcutaneous hepatocellular carcinoma xenograft.

K. Glaser, S. Davidsen, D. Albert, 2008, Journal of hepatology.